Globus Medical, Inc. GMED
79.58 USD +0.12 (+0.15%)
At closeNov 4, 2026, 8:24 AM EST
78.00 -1.58 -1.99%
Pre-market · Nov 4, 8:24 AM ET
78.61 Day range 80.20
60.26 52-week range 101.40
- YTD
- -8.85%
- 1 year
- +29.06%
News
benzinga.com Globus Medical Acquires Synaptive Medical; Financial Terms Not Disclosed Globus Medical, Inc. a leading musculoskeletal technology company, today announced that it completed the acquisition of Synaptive Medical, deepening the Company's presence in cranial neurosurgery and…
seekingalpha.com Globus Medical: The Shrinking Robot Line Hides A Growing Annuity Globus Medical is leveraging flexible leasing models to expand its installed base, prioritizing recurring high-margin implant sales over upfront capital revenue. GMED's post-NuVasive integration is…
zacks.com GMED vs. AXGN: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and AxoGen (AXGN). But which of these two companies is the best option for…
zacks.com Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet The consensus price target hints at a 30.5% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings…
zacks.com Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com 2 Healthcare Technology Stocks for a Digital Health Boom GMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.
benzinga.com Globus Medical Q2 2026 Earnings Call Transcript On Thursday, Globus Medical (NYSE:GMED) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For…
benzinga.com RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $85 RBC Capital analyst Kendall Au maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $115 to $85.
benzinga.com Globus Medical Receives CE Mark For Its Excelsius3D Imaging System For Commercial Sale In EU, U.K. Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced that the Excelsius3D™ intelligent 3-in-1 imaging system is now CE marked for commercial sale in the…
benzinga.com Globus Medical To Acquire Higgs Boson Health; Financial Terms Not Disclosed Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced the acquisition of Higgs Boson Health, a digital healthcare experience company based in Durham, NC and…
benzinga.com Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99 Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $103 to $99.
benzinga.com Globus Medical Raises FY2026 Adj EPS Guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.201B Est Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 analyst estimate. Affirms FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.180…
benzinga.com Globus Medical Q2 Adj. EPS $1.34 Beats $1.10 Estimate, Sales $789.612M Beat $782.840M Estimate Globus Medical (NYSE:GMED) reported quarterly earnings of $1.34 per share which beat the analyst consensus estimate of $1.10 by 21.82 percent. This is a 55.81 percent increase over earnings of $0.86…- benzinga.com Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100 Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $115 to $100.
- benzinga.com RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115 RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $120 to $115.
- benzinga.com BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94 BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announces Price Target of $94.
- benzinga.com Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80 Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price target from $95 to $80.
benzinga.com AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market Today Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end
benzinga.com Paychex To Rally More Than 39%? Here Are 10 Top Analyst Forecasts For Monday Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst ratings page. Barclays, Wells Fargo, Piper Sandler, Leerink Partners, Truist Securities, and…- benzinga.com Piper Sandler Maintains Overweight on Globus Medical, Lowers Price Target to $100 Piper Sandler analyst Matt O'Brien maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $115 to $100.
benzinga.com Jim Cramer Flags Industrial Company With 'Almost No Revenue,' Says No To Rocket Companies Cramer says Rocket Companies is a "play" on the idea that new Fed Chair Kevin Warsh will cut interest rates, and that's a long shot.- benzinga.com RBC Capital Maintains Outperform on Globus Medical, Raises Price Target to $120 RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raises the price target from $115 to $120.
benzinga.com Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $103 Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $104 to $103.- benzinga.com Needham Maintains Buy on Globus Medical, Raises Price Target to $117 Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $114 to $117.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com Globus Medical Raises FY2026 Adj EPS Guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.202B Est Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 analyst estimate. Affirms FY2026 sales outlook from $3.180 billion-$3.220 billion to $3.180…
- benzinga.com Globus Medical Q1 Adj. EPS $1.12 Beats $0.92 Estimate, Sales $759.854M Beat $736.999M Estimate Globus Medical (NYSE:GMED) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $0.92 by 21.74 percent. This is a 64.71 percent increase over earnings of $0.68…
- benzinga.com Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $104 Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $98 to $104.
- benzinga.com Barclays Maintains Overweight on Globus Medical, Raises Price Target to $123 Barclays analyst Matt Miksic maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $118 to $123.
benzinga.com 8 Analysts Assess Globus Medical: What You Need To Know - benzinga.com Needham Maintains Buy on Globus Medical, Raises Price Target to $114 Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $112 to $114.
benzinga.com Earnings Scheduled For February 24, 2026 
benzinga.com Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? Expedia, SanDisk, and Penumbra led last week's large-cap gainers, with strong earnings and raised guidance fueling broad double-digit jumps.
benzinga.com Nasdaq Tumbles Over 100 Points; US Consumer Sentiment Falls In November 
benzinga.com Dropbox, Globus Medical, Expedia, Genpact And Other Big Stocks Moving Higher On Friday 
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session 
benzinga.com This Expedia Group Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com Earnings Scheduled For August 7, 2025
benzinga.com This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday 
benzinga.com Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com Earnings Scheduled For May 8, 2025
- benzinga.com Earnings Scheduled For February 20, 2025
- benzinga.com Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - benzinga.com 10 Health Care Stocks With Whale Alerts In Today's Session
- benzinga.com Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September.
- benzinga.com Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session